The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

nitronex.com

Founded Year

1999

Stage

Acquired - II | Acquired

Total Raised

$107.21M

Valuation

$0000 

Revenue

$0000 

About Nitronex

Nitronex specializes in the development and manufacturing of gallium nitride-on-silicon (GaN-on-Si) RF power devices. Based on the SIGANTIC process, gallium nitride on silicon technology, Nitronex commercializes GaN technology for RF applications. The company's ability to combine the disciplines of material growth, wafer processing, device design and wireless applications knowledge is unique to the industry.

Nitronex Headquarter Location

2305 Presidential Drive

Durham, North Carolina, 27703,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Nitronex

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Nitronex is included in 1 Expert Collection, including Semiconductors, Chips, and Advanced Electronics.

S

Semiconductors, Chips, and Advanced Electronics

6,091 items

Companies in this collection develop everything from microprocessors to flash memory, integrated circuits specifically for quantum computing and artificial intelligence to OLED for displays, massive production fabs to circuit design firms, and everything in between.

Nitronex Patents

Nitronex has filed 5 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/1/2008

9/7/2010

Indium compounds, Gallium compounds, Nitrides, Spectroscopy, Solar cells

Grant

Application Date

2/1/2008

Grant Date

9/7/2010

Title

Related Topics

Indium compounds, Gallium compounds, Nitrides, Spectroscopy, Solar cells

Status

Grant

Latest Nitronex News

MACOM announces final order of preliminary injunction against Infineon

Dec 16, 2016

MACOM Technology Solutions Holdings Inc of Lowell, MA, USA (which makes semiconductors, components and subassemblies for analog RF, microwave, millimeter-wave and photonic applications) says that the US District Court for the Central District of California in Los Angeles has entered a preliminary injunction order that bars Infineon Technologies Americas Corp from designing, developing, making, marketing or selling gallium nitride on silicon (GaN-on-Si) RF products that use intellectual property rights previously owned by Nitronex and now exclusively licensed to MACOM in certain fields, including base-stations. The order further requires Infineon to provide notice of the injunction to all its relevant affiliates, subsidiaries, employees, and customers. Previously, on 31 October, the court issued a decision that (i) confirmed MACOM's continuing exclusive rights in certain GaN-on-Si RF fields under a 2010 license agreement between Nitronex LLC of Durham, NC, USA (acquired by MACOM for $26m in February 2014) and International Rectifier (acquired by Infineon in 2015); (ii) ruled that MACOM is likely to succeed in its claim that Infineon's purported termination of that agreement was improper and without effect; and (iii) granted MACOM's motion for a preliminary injunction prohibiting Infineon from engaging in activities inconsistent with the 2010 license agreement (pending the court's final decision, announced now). When MACOM initiated the legal action in April, it alleged that Infineon had attempted to interfere with and usurp MACOM's rights under certain agreements between Nitronex and International Rectifier. "Nitronex and IR, and later, MACOM and IR, successfully collaborated for many years. Problems developed only after Infineon acquired IR and began to try to 'renegotiate' the Nitronex-IR agreements to reduce MACOM's rights," said MACOM's president & CEO John Croteau. "When MACOM declined to accede to Infineon's demands, Infineon concocted claims to interfere with our rights under the agreements," he alleged. "Infineon's behavior is clear validation that MACOM's GaN technology – the product of 15 years and over $100m in investment – is at the tipping point of market adoption, threatening large incumbents like Infineon," continued Croteau. MACOM's suit against Infineon includes claims for breach of contract, breach of the covenant of good faith and fair dealing, declaratory judgment of contractual rights, and intentional interference with contract. Among other relief, MACOM asked the court to grant it declaratory and injunctive relief confirming its rights under the Nitronex-IR agreements and ordering Infineon to assign to MACOM several Nitronex GaN patents. "Our US court system demands an extremely high standard of proof before it will consider issuing a preliminary injunction," says Croteau now about the court's final decision. "We are fully committed to vigorously litigating this case to its rightful conclusion and stand firmly against any company resorting to strong-arm tactics to usurp the rights of pioneers and innovators who move the industry and society forward with breakthrough technologies like GaN-on-Si in base-stations," he adds. See related items:

  • When was Nitronex founded?

    Nitronex was founded in 1999.

  • Where is Nitronex's headquarters?

    Nitronex's headquarters is located at 2305 Presidential Drive, Durham.

  • What is Nitronex's latest funding round?

    Nitronex's latest funding round is Acquired - II.

  • How much did Nitronex raise?

    Nitronex raised a total of $107.21M.

  • Who are the investors of Nitronex?

    Investors of Nitronex include MACOM, Gaas Labs, ARCH Venture Partners, Alloy Ventures, InterSouth Partners and 13 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.